Dr. Mehdi Jorfi completed his Ph.D. in Neural Engineering at the University of Fribourg, Switzerland. During his Ph.D., he executed a multi-institutional experimental research program on developing biologically-inspired mechanically-dynamic intracortical microelectrodes for neural interfacing. This work derived fundamental insights into our understating of the multifaceted role that neuroinflammation may play ...
February 22, 2021
Dr. Mazziotta is a pioneer and leader in applying imaging technology to our understanding of the functions of the brain. His research, teaching, writing and presentations have furthered developments in brain mapping through the use of such technologies as Position Emission Tomography. He is currently leading the International Consortium of ...
March 5, 2017
Dr. Lee is a world renowned leader in research on tau, alpha-synuclein and the beta-amyloid precursor protein and their pathobiological roles in such neurodegenerative diseases as Alzheimer’s disease, Parkinson’s disease and frontotemporal dementias. In particular, Dr. Lee is attempting to determine the pathogenic roles of the abnormal proteins comprising senile ...
April 23, 2017
Alzheimer’s Disease: A research update Farm Neck Golf Club, Oak Bluffs, Marthaās Vineyard Monday, August 20, 2012 5:00 p.m. – 7 p.m. The event will begin with a Reception starting at 5:00 p.m., with the Presentation starting at 6 p.m. and ending at 7 p.m.Ā The talk is jointly sponsored by Cure Alzheimer’s Fund and ...
July 11, 2012
Alzheimer’s disease (AD) is a neurodegenerative disease caused by poorly known pathogenetic mechanisms and aggravated by delayed therapeutic intervention; it still lacks an effective cure. However, it is clear that some important neurophysiological processes are altered years before the onset of clinical symptoms, offering the possibility of identifying biological markers ...
January 11, 2024
The Fall 2006 Quarterly Report features an article on Alzheimer’s Disease and Vaccines, a fundraising update, a question and answer about Intellectual Property and an Update from Founder Phyllis Rappaport.
February 19, 2018
In an effort to educate the public about the state of Alzheimerās disease and the urgent need for research funding, Cure Alzheimerās Fund has held more than a dozenĀ State of the Mind presentationsĀ across the country this past year, each one featuring a leading scientist who has received a research grant. ...
February 19, 2018
Recent evidence suggests that molecular markers of Alzheimerās disease may differ by race, but existing studies have been limited by small sample sizes. The Alzheimerās Disease Research Centers at Washington University in St. Louis and Emory University have embarked on a collaboration to share spinal fluid and plasma samples from ...
February 18, 2020
Alzheimerās disease (AD) is the most common contributor to dementia in the United States. AD is a disorder in which the aggregation and accumulation of amyloid beta and tau play key roles in pathogenesis. Autosomal-dominant Alzheimerās disease (ADAD), or Dominantly Inherited AD (DIAD), is a rare form of AD, and ...
March 19, 2024
June 26, 2024
